LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz
Media Pack
News

Current Edition

Volume 17, Issue 1
Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Bespak – 21.05.2025
Stoelzle – 15th May 2025
On its Way: New ISO Standard on Interoperability of Anti-Counterfeit Systems, Based on Unique Identifiers
Packaging V6I4

On its Way: New ISO Standard on Interoperability of Anti-Counterfeit Systems, Based on Unique Identifiers

Identification systems based on unique identifiers are no longer restricted to individuals' ID cards, car plates or telephone numbers. For many years now, object ide...
17 December 2014 Packaging V6I4 | Volume 6 Issue 4
Continue Reading →
Beyond Item-level Serialisation: Extending Traceability Schemes to Secondary and Tertiary Packaging
Packaging V6I4

Beyond Item-level Serialisation: Extending Traceability Schemes to Secondary and Tertiary Packaging

The challenges of serialisation are well-documented; however aggregation requires an altogether higher level of data processing and joined-up thinking. Inserting the...
17 December 2014 Packaging V6I4 | Volume 6 Issue 4
Continue Reading →
Implementing Serialisation
Manufacturing V6I4

Implementing Serialisation

The subject of serialisation and track-and-trace has been on the industry's agenda for quite some time. Several of the major drug manufacturers have, in fact, made c...
17 December 2014 Manufacturing V6I4 | Volume 6 Issue 4
Continue Reading →
Advances in Tissue Processing: The Supercritical Alternative
Manufacturing V6I4

Advances in Tissue Processing: The Supercritical Alternative

Despite the promising future use of stem cells, extensive research over the last decade has shown how the augmentation of, e.g., damaged tissue not only depends on t...
17 December 2014 Manufacturing V6I4 | Volume 6 Issue 4
Continue Reading →
Temperature Mapping of Vehicles Used for the Transportation of Pharmaceutical Products
Labs & Logistics V6I4

Temperature Mapping of Vehicles Used for the Transportation of Pharmaceutical Products

Andy Hughes of Pharmafreight UK and Kane Edgeworth of Biomap Ltd talk about the recent history of temperature-mapping expectations, the approach of mapping temperatu...
17 December 2014 Labs & Logistics V6I4 | Volume 6 Issue 4
Continue Reading →
Transforming Temperature Data Management Practices to Reduce Labour Costs and Improve Visibility and Control
Labs & Logistics V6I4

Transforming Temperature Data Management Practices to Reduce Labour Costs and Improve Visibility and Control

Central to the good distribution practices of a biopharma company is the reliability and traceability of temperature data associated with temperature-sensitive shipm...
17 December 2014 Labs & Logistics V6I4 | Volume 6 Issue 4
Continue Reading →
Securing the Global Pharmaceutical Supply Chain Against the Threat of Counterfeit Drugs
Labs & Logistics V6I4

Securing the Global Pharmaceutical Supply Chain Against the Threat of Counterfeit Drugs

According to the WHO, the prevalence of spurious, falsely-labelled, falsified, or counterfeit medicines, or SFFC medicines as they are known ? medicines that are del...
17 December 2014 Labs & Logistics V6I4 | Volume 6 Issue 4
Continue Reading →
Logistics: The Power of Clinical Trial Supply Visibility
Labs & Logistics V6I4

Logistics: The Power of Clinical Trial Supply Visibility

As a result of the globalisation of clinical trials, one of the biggest challenges that pharmaceutical companies face is the management of the clinical trial supply ...
17 December 2014 Labs & Logistics V6I4 | Volume 6 Issue 4
Continue Reading →
Advocating an Integrated Approach to the Global Diabetes Epidemic
Clinical Research V6I4

Advocating an Integrated Approach to the Global Diabetes Epidemic

The non-communicable disease of diabetes has reached epidemic proportions, and it knows no geographic boundaries. It`s time to take a sombre look at the consequences...
17 December 2014 Clinical Research V6I4 | Volume 6 Issue 4
Continue Reading →
Opportunities for Monoclonal Antibodies in Bacterial Infectious Diseases
Clinical Research V6I4

Opportunities for Monoclonal Antibodies in Bacterial Infectious Diseases

The management of infectious disease is challenged by trends that impact patient welfare on a global scale; the emergence of multi-drug-resistant (MDR) forms of new ...
17 December 2014 Clinical Research V6I4 | Volume 6 Issue 4
Continue Reading →
Scott Pharma – 25.03.2025
SMI – 24/03/2025
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
L.B. Bohle – 08.04.2025
logo-ipi-w.png

International Pharmaceutical Industry

IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative

Facebook Linkedin Tumblr
IPI Media © 2025, All Rights Reserved – Powered by Teksyte